awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38631019-20EE81D3-5E6A-4DB8-AFA2-B38EFF90B347
Q38631019-20EE81D3-5E6A-4DB8-AFA2-B38EFF90B347
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38631019-20EE81D3-5E6A-4DB8-AFA2-B38EFF90B347
Treatment of ALK-rearranged non-small cell lung cancer: A review of the landscape and approach to emerging patterns of treatment resistance in the Australian context.
P2860
Q38631019-20EE81D3-5E6A-4DB8-AFA2-B38EFF90B347
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38631019-20EE81D3-5E6A-4DB8-AFA2-B38EFF90B347
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
11cdd779bf7b26abb1ec7a7f2d1fd30111ae04a7
P2860
Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2.